148 related articles for article (PubMed ID: 19555244)
1. Transdermal delivery of carvedilol in rats: probing the percutaneous permeation enhancement mechanism of soybean extract-chitosan mixture.
Sapra B; Jain S; Tiwary AK
Drug Dev Ind Pharm; 2009 Oct; 35(10):1230-41. PubMed ID: 19555244
[TBL] [Abstract][Full Text] [Related]
2. Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study.
Sapra B; Jain S; Tiwary AK
AAPS PharmSciTech; 2009; 10(1):199-210. PubMed ID: 19238554
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation.
Sapra B; Jain S; Tiwary AK
Drug Deliv; 2008 Sep; 15(7):443-54. PubMed ID: 18712622
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
5. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug.
Dixit N; Kohli K; Baboota S
PDA J Pharm Sci Technol; 2008; 62(1):46-55. PubMed ID: 18402367
[TBL] [Abstract][Full Text] [Related]
6. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.
Ubaidulla U; Reddy MV; Ruckmani K; Ahmad FJ; Khar RK
AAPS PharmSciTech; 2007 Jan; 8(1):2. PubMed ID: 17408218
[TBL] [Abstract][Full Text] [Related]
7. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of carvedilol transdermal patches.
Tanwar YS; Chauhan CS; Sharma A
Acta Pharm; 2007 Jun; 57(2):151-9. PubMed ID: 17507312
[TBL] [Abstract][Full Text] [Related]
9. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis.
Krishnaiah YS; Satyanarayana V; Karthikeyan RS
J Pharm Pharm Sci; 2002; 5(2):123-30. PubMed ID: 12207864
[TBL] [Abstract][Full Text] [Related]
10. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of a bioadhesive film for transdermal delivery of propranolol hydrochloride.
Rasool BK; Aziz US; Sarheed O; Rasool AA
Acta Pharm; 2011 Sep; 61(3):271-82. PubMed ID: 21945906
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension.
Di Verniero CA; Bertera F; Buontempo F; Bernabeu E; Chiappetta D; Mayer MA; Bramuglia GF; Taira CA; Höcht C
J Pharm Pharmacol; 2010 Jul; 62(7):890-900. PubMed ID: 20636877
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: in vitro, pharmacokinetic and pharmacodynamic investigations.
Yedurkar P; Dhiman MK; Petkar K; Sawant K
J Microencapsul; 2012; 29(2):126-37. PubMed ID: 22047549
[TBL] [Abstract][Full Text] [Related]
14. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
Ahmed TA; El-Say KM
Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of in vitro percutaneous absorption enhancement of carvedilol by penetration enhancers.
Amin S; Kohli K; Khar RK; Mir SR; Pillai KK
Pharm Dev Technol; 2008; 13(6):533-9. PubMed ID: 18720242
[TBL] [Abstract][Full Text] [Related]
16. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
17. Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study.
Agrawal SS; Aggarwal A
Contemp Clin Trials; 2010 Jul; 31(4):272-8. PubMed ID: 20382272
[TBL] [Abstract][Full Text] [Related]
18. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol.
Wei L; Li J; Guo L; Nie S; Pan W; Sun P; Liu H
Drug Dev Ind Pharm; 2007 Sep; 33(9):990-8. PubMed ID: 17891586
[TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive chitosan microspheres of carvedilol for nasal administration.
Patil S; Babbar A; Mathur R; Mishra A; Sawant K
J Drug Target; 2010 May; 18(4):321-31. PubMed ID: 20199172
[TBL] [Abstract][Full Text] [Related]
20. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
